Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Skin Cancer01:30

Skin Cancer

5.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PIP4K2A/2B inhibitor suppresses tumor growth in a xenograft model of NSCLC.

iScience·2026
Same author

Cost Consequences Associated With Biologic Therapy Switching in Publicly Insured Psoriasis Individuals in the United States.

International journal of dermatology·2026
Same author

Clonal determinants of organotropism and survival in metastatic uveal melanoma.

NPJ precision oncology·2026
Same author

Lipophilic Statins Deplete GPX4 to Promote Ferroptosis and Sensitize Cancer Cells to Immune Checkpoint Blockade.

Molecular cancer therapeutics·2025
Same author

Retraction Note: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.

Nature·2025
Same author

Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same journal

RETRACTED: Sabir et al. DNA Based and Stimuli-Responsive Smart Nanocarrier for Diagnosis and Treatment of Cancer: Applications and Challenges. <i>Cancers</i> 2021, <i>13</i>, 3396.

Cancers·2026
Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026
Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026
Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026
Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026
Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.3K

Decoding melanoma metastasis.

William E Damsky1, Lara E Rosenbaum, Marcus Bosenberg

  • 1Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA. marcus.bosenberg@yale.edu.

Cancers
|November 12, 2013
PubMed
Summary
This summary is machine-generated.

Metastasis drives melanoma mortality, with specific organ predilection. Understanding the complex mechanisms of melanoma spread, including microenvironment factors and genetic drivers, is crucial for developing effective treatments.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

18.1K
Experimental Metastasis Assay
08:28

Experimental Metastasis Assay

Published on: August 24, 2010

20.3K

Related Experiment Videos

Last Updated: May 6, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.3K
A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

18.1K
Experimental Metastasis Assay
08:28

Experimental Metastasis Assay

Published on: August 24, 2010

20.3K

Area of Science:

  • Oncology
  • Cancer Biology
  • Dermatology

Background:

  • Metastasis is the primary cause of death in melanoma patients.
  • Melanoma exhibits organ-specific metastatic patterns.
  • Metastatic processes are influenced by tumor microenvironment and genetic factors.

Purpose of the Study:

  • To elucidate the complex mechanisms of melanoma metastasis.
  • To understand organ specificity in melanoma spread.
  • To integrate temporal complexity and heterogeneity into melanoma metastasis models.

Main Methods:

  • Experimental analyses of melanoma cell dissemination.
  • Investigation of genetic drivers of melanoma.
  • Evaluation of extrinsic microenvironmental factors influencing metastasis.

Main Results:

  • Melanoma metastasis involves complex temporal dynamics and heterogeneity.
  • Organ specificity is influenced by both intrinsic tumor factors and extrinsic microenvironment.
  • Metastatic dormancy and pre-malignant melanocyte dissemination complicate analyses.

Conclusions:

  • Current models of melanoma metastasis require revision to incorporate temporal complexity and heterogeneity.
  • Both genetic drivers and extrinsic regulators are critical for understanding melanoma spread.
  • Further research is needed to target organ-specific metastatic pathways.